Name: CorDx Tyfast SARS-CoV-2/Flu A+B Rapid Antigen Test
Brand: CorDx
SKU: ACT21001-25
Price: 133.75 USD
Availability: InStock

CorDx Tyfast SARS-CoV-2/Flu A+B Rapid Antigen Test

$133.75 USD

CorDx Tyfast SARS-CoV-2/Flu A+B Rapid Antigen Test

$133.75 USD $5.35 USD each

NOTE: Interested in buying a larger quantity? Please contact us at info@summitmedpartners.com for pricing.

Lateral flow immunoassay for rapid, simultaneous detection of SARS-CoV-2, influenza A, and influenza B from anterior nasal swab specimens. Best used within the first five days of symptom onset. Results within 10 minutes. CLIA Waived. No equipment required. COVID-19: 89.6% sensitivity, 99.8% specificity. Flu A: 85.0% sensitivity, 99.2% specificity. Flu B: 87.5% sensitivity, 99.8% specificity. Includes 25 test cassettes, 25 swabs, and 25 tubes with sample processing solution. 25 tests per box.

Status™ Mono (with controls) Rapid Point-of-Care Test is an immunoassay for the qualitative detection of infectious mononucleosis IgM heterophile antibodies in serum, plasma, or whole blood.

Features and Benefits:

Single reagent procedure
Sensitivity 99.9%; Specificity 98.8%
No age restrictions
Serum, plasma or whole blood
Delivers results within 8 minutes
No equipment necessary
CLIA Waived Test

Each Status Mono test kit includes enough materials for 25 tests.

Regulatory Status: CLIA Waived (whole blood) / Moderately Complex (serum / plasma) / Professional Use Only

Contents: (25) Test devices, (25) Transfer Pipettes, (1) Developer Solution, (1) Mono Positive Control, (1) Mono Negative Control, (1) Package Insert, (1) Procedure Card

Determinations: Qualitative Infectious Mononucleosis

Storage Requirements: 36° – 86° F

Processing Time: 8 Minutes